Methods of staphylococcal enterotoxin directed cell-mediated cyt

Details Methods of staphylococcal enterotoxin directed cell-mediated cyt Methods of staphylococcal enterotoxin directed cell-mediated cyt

1996-02-05

2000-03-28

Cunningham, Thomas M.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

4242341, 4242431, 530350, A61K 39085

Patent

active

060428376

ABSTRACT:
Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC), including methods of lysing malignant cells expressing MHC Class II antigens using SDCC, by the administration of staphylococcal enterotoxin to a living body.

REFERENCES:
patent: 3627644 (1971-12-01), Okamoto et al.
patent: 4237224 (1980-12-01), Cohen et al.
patent: 4268434 (1981-05-01), Higerd et al.
patent: 4677064 (1987-06-01), Mark et al.
patent: 4681870 (1987-07-01), Balint, Jr. et al.
patent: 4689222 (1987-08-01), McMichael
patent: 4699783 (1987-10-01), Terman et al.
patent: 4791101 (1988-12-01), Adolf
patent: 4816441 (1989-03-01), Zeuthen et al.
patent: 4980160 (1990-12-01), Goldberg et al.
patent: 5091091 (1992-02-01), Terman
patent: 5362490 (1994-11-01), Kurimoto et al.
Murphy et al., Staphylococcal Protein A Adsorption in neoplastic disease: Analysis of physicochemical aspects. Mol. Biother., 1 (1989) 186-207.
Solal-Celigny et al., Effects of ex-vivo plasma absorption over protein A sepharose in acute leukemia. Leukemia Research 10(6) (1986) 643-49.
Platsoucas et al., Immunomodulation of human leucocytes by staphylococcal enterotoxin A; augmentation of natural killer cells and induction of suppressor cells. Cell. Immunol. 97 (1986) 371-385.
Smith et al., Staphylococcal aureus protein A induces the production of interferon-alpha in human lymphocytes and interferon-alpha/beta in mouse spleen cells. J. Immunol. 13-0 (1983) 773-776.
Carlsson et al., Staphylococcal protein A (SpA) does not induce production of interferon-gamma in human mononuclear blood cells. Cell. Immunol. 86 (1984) 136-144.
Branda et al., Further characterization of the in vitro tumoricidal activity of staphylococcal protein A. Cancer Research 46 (1986) 2610-2613.
Weiss R., Immunotherapy for feline leukemia, using staphylococcal protein A or heterologous interferons: immunopharmacologic actions and potential use. J. Am. Vet. Med. Assoc., 192 (Mar. 1988), 681-684.
Garcia-Penarrubia et al. Selective proliferation of natural killer cells among monocyte-depleted peripheral blood mononuclear cells as a result of stimulation with staphylococcal enterotoxin B. Infection and Immunity, 57 (Jul. 1989) 2057-2065.
Fischer et at. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines. J. Immunol. 142 (1989) 3151-3157.
Carswell et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci., 92 (9) (1975) 3666-3670.
Fast et al. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infection and Immunity, 57 (Jan. 1989) 291-294.
Schrezenmeir and Fleischer. Mitogenic activity of staphylococcal protein A is due to contaminating staphylococcal enterotoxins. J. Immunol. Meth. 105 (1987) 133-137.
Carlsson et al. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J. Immunol. 140 (1988) 2484-2488.
Scheglovitova et al. Inteferon production and natural killer activity induced by staphylococcal enterotoxins in mouse spleen cells. Vopr. Virusol. 33 (3) (May-Jun. 1988) 305-309.
Terman and Bertram. Antitumor effects of immobilized protein A and staphylococcal products: Linkage between toxicity and efficacy, and identification of potential tumoricidal reagents. Eur. J. Clin. Oncol. 21 (1985) 1115-1122.
Abstract No. 84048345, Biological Abstracts, Journal Article.
Abstract No. 88075810, Biological Abstracts, Journal Article.
Abstract No. 88087362, Biological Abstracts, Journal Article.
Hamaoka, T., Immunology Today, vol. 8, No. 9, 1987, "Phenotypically and Functionally Distinct T-Cell Subsets in Anti-Tumor Responses".
Fleischer, B., In: Cellular Immunology, 120: 92-101, 1989.
Roitt, et al., Immunology, pp. 18.7, 13.3, 23.8, 23.9.
Fraser, J.D., In: Nature, 339: 221-223, May, 1989.
Matthes, M., et al., In: European Journal of Immunology, 18: 1733-1737, 1988.
Stuart, P.M. et al., Journal of Immunology, 142: 3392-3399, 1989.
Nauts, "Beneficial Effects of Immunotherapy (Bacterial Toxins) on Sarcoma of the Soft Tissues, Other than Lymphosarcoma", Cancer Research, Inc., New York, NY, pp. 1-25 & 205-219, 1975.
Coley, Treatment of inoperable Sarcoma, "Surgical Section", Pro Royal Soc. Med, 1910/1911; 3:1-48.
Hedlund, Cellular Immunology, 129:426-434, 1990.
Paul, W.F. (ed), Fundamental Immunology, 3rd Edition, pp. 80-81, 403-405, 1038-1040 & 1296, 1993.
Held, et al., Immunology Today, 15(4): 184-193, Apr., 1994, "Superantigens and retroviral infection; insights from mouse mammary tumor virus".
Wallgren et al., Blood, 82:1230-1238, 1993.
Dohlsten, M., Immunology, 79:520-527, 1993.
Belfrage, et al. Cancer Immunology, 38:265-271, 1994.
White, J. et al., Cell, 56:27-35, Jan., 1989.
Hedlund, et al., Cancer Immunol. Immunother, 36: 89-93, 1993.
Kappler, et al., Science, 244: 811-813, 1989.
Shcheglovitova, et al., "Non-Specific Anti-tumour Activity of Staphylococcal Exterotoxins"--Paper.
Shcheglovitova, et al., "The Effect of Staphylococcal Exterotoxins A-Sensitized Spleen Cells on the Metastatic Spreading of Lewis Lung Carcinoma in Mice" Eksp. Onkol. 11:54-56 (1989).
Shcheglovitova, et al., "The Effect of Staphylococcal Exterotoxins A on the Development of Lewis Lung Carcinoma in Mice"--Eksp. Onko 11:73-79 (1989.
Bergdoll, M., In: Staphylococci and Staphyloccocal Infections, C.S.F. Easman and C. Adam (eds) Acad. Press, New York, pp. 559-598, 1983.
Carlsson, R., et al., Cell. Immunology, 96:175-181, 1985.
Fischer, H., et al., The J. of Immunol., 142: 3151-3157, May, 1989.
Fischer, J., et al., The J. of Immunol., 144: 4663-4669, Jun., 1990.
Guillemot, F. et al, In: Molecular Immunology, B.J. Hames and D.M. Glover (eds), IRL Press, Oxford, pp. 81-143.
Lando, P., et al., Scand. J. Immunol., 31: 133-138, 1990.
Langford, M., et al., Infection and Immunol., 22, No.1: 62-68, Oct., 1978.
Mollick, J., et al. Science, 244: 817-820, 1989.
J. Immunology, 122:549-554, 1979.
J. Exp. Med., 155:445, 1982.
Cancer Chemother Res., 3:325, 1972.
Cancer Res, 15:38, 1985.
Lando, P. et al., Scand. J. Immunol., "The TCR-CD3 Complex is required for activation of human lymphocytes with Staphlococcal Exterotoxins A", 1989.
Dellabona et al., Cold Springs Haub. Symp. Quant. Biol., 54:t (1989) 1:373.
Blackman et al., Immunol. Rev., 101:5-19, (1988).
Beardsley, Sci. Am., 261:1, 1989.
Kappler, et al, Cold Springs Haub. Symp. Quant. Biol., 54:t (1989) 1:401.
Rich et al., Trans. Am. Clin. Climatol. Assoc., 101:15, 1989.
Nauts, Beneficial Effects of Immunotherapy (Bacterial Toxins) on Sarcoma of the Soft Tissues, Other than Lymphosarcoma, Cancer Research Institute Inc., New York, NY, 1975, pp. 1-25 and 205-219.
Fraser, J.D. , In: Nature, 339: 221-223, May 1989.
Stuart, M. P., et al., In: The Journal of Immunology, 142: 3392-3393, May, 1989.
Carlsson, R., et al., Cell. Immunol., 96: 175-181, 1985.
Fischer, W., et al., The J. of Immunol., 142: 3151-3157, May, 1989.
Fischer, W., et al., The J. of Immunol., 144: 4663-4669, Jun., 1990.
Guilemot, F. et al., In: Molecular Immunology, B.J. Hames and D.M. Glover (Eds), IRL Press, Oxford, 1988, pp. 81-143.
Langford, M., et al., Infection and Immunol., 22,No.1: 62-68, Oct. 1978.
Mollick, J., et al., Science, 244: 817-820, 1989.
White, J. et al., Cell, 56: 27-35, Jan., 1989.
Scheglovitova et al, Vopr. Virusol. 32(3):327-329, "Use of enterotoxins adsorbed on filters for induction of human immune interferon", 1987.
Alakhov et al., Biotechnol. Appl. Biochem. 10:563-7, "The effect os Staphylococcus aureus enterotoxin A on proliferation of lymphoid and nerve cells", 1988.
Andersson et al., J. Immunol. Methods 123:233-240, "Characterization of individual tumor necrosis factor alpha and beta-producing cells after polyclonal T cell activation", 1989.
Johnson et al., Int. Arch. Aleergy Appl.Immunol. 87:87-90, "Potent mitogenic activity of staphylococcal enterotoxin A requires induction of interleukin 2", 1988.
Office Action in 08/596,555 with attachments.
Communication regarding EPO Application No. 91 903 963.6-2110 (David S. Terman et al.).
Opposition to EP-B-444186 (90914564.1)

Affiliated with

Also associated with

Rating

Methods of staphylococcal enterotoxin directed cell-mediated cyt does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of staphylococcal enterotoxin directed cell-mediated cyt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of staphylococcal enterotoxin directed cell-mediated cyt will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1323795